Anticoagulation is the answer in treating noncritical COVID-19 patients
All autopsy studies demonstrated widespread thrombosis and alveolar-capillary microthrombi as the cause of death among patients with COVID-19. The autopsy studies are the gold-standard for diagnostic accuracy and therapeutic strategies for any clinical scenarios. The author initially observed that p...
Guardado en:
Autor principal: | Kabir Azad A. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d03ee627fd0b47009eba430173062847 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characteristics and treatment of coagulopathy associated with COVID-19
por: Miljić Predrag
Publicado: (2021) -
Beneficial Effects of Anticoagulants on the Clinical Outcomes of COVID-19 Patients
por: Zubia Jamil, et al.
Publicado: (2021) -
Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital
por: Antonio Adolfo Guerra Soares Brandão, et al.
Publicado: (2021) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam MK, et al.
Publicado: (2015) -
Direct oral anticoagulants; a review for the non-specialist
por: Thilina Gunawardena
Publicado: (2021)